Biotech feed’s Post

Hydrocephalus shunts market share in Israel: recent trends According to GlobalData, Medtronic is the leading hydrocephalus shunts manufacturer within Israel in 2023 The post Hydrocephalus shunts market share in Israel: recent trends appeared first on Medical Device Network.... https://lnkd.in/ecksMkJd #BioTech #science

Sigmoidoscopes market share in Portugal: recent trends According to GlobalData, PENTAX Medical is the leading sigmoidoscopes manufacturer within Portugal in 2023 The post Sigmoidoscopes market share in Portugal: recent trends appeared first on Medical Device Network.... https://lnkd.in/ejjzgruy #BioTech #science

🌐 𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐄𝐱𝐜𝐞𝐥𝐥𝐞𝐧𝐜𝐞 𝐰𝐢𝐭𝐡 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐆𝐚𝐬𝐞𝐬! 💉 🔍 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐲𝐨𝐮𝐫 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲: https://lnkd.in/euVE_FzG 𝐒𝐮𝐦𝐦𝐚𝐫𝐲: The global Medical Gases Market was valued at USD 13.75 billion in 2022 and is set to expand at a CAGR of 8.14% from 2023 to 2030. Medical gases play a crucial role across hospitals, clinics, research institutions, and home healthcare, ensuring life-saving treatments and advanced medical care. 𝐁𝐲 𝐓𝐲𝐩𝐞: -Medical Oxygen -Medical Nitrous Oxide -Medical Air -Medical Helium 𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬: -Hospitals (Labs & Clinics) -Home Healthcare -Universities/Research Institutions -Pharmaceutical & Biotechnology Industries 𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬: -Air Liquide -Praxair, Inc - a Linde Company -Air Products -Taiyo Nippon Sanso Innovation -Messer Americas -SOL Group -Air Water Inc. -Norco -Linde Healthcare -Shenzhen Gaofa #MedicalGases #HealthcareInnovation #AirLiquide #LindeHealthcare #Praxair #TaiyoNippon #MesserGroup #SOLGroup #MedicalOxygen #MedicalTechnology #Hospitals #SNR Stats And Research

📌 NABIHEAL project | 18-month progress meeting 🚀 Very productive meeting in the beautiful city of Aarhus! The project is now in its month 18 and moving forward with good results on antimicrobial activity in the developed biomaterials. The NABIHEAL partners met in Denmark to review the progress and discuss next steps.  🤝🏽 ASPHALION, as the regulatory partner of the project, helped identify which information should be collected before contacting #RegulatoryAuthorities to validate the qualification of the first candidate as a medical device.   🔗 Read more about the project here: https://bit.ly/3VIeLJC #Horizon #EUfunded #WoundTreatment #WoundInfections #RA #RegulatoryAffairs #WeAreAsphalion #WeCare #KnowledgeFromExperience

Global Biosensors and Nanosensors Market and Technology Analysis 2024-2028 - ResearchAndMarkets.com DUBLIN--(BUSINESS WIRE)--The "Biosensors and Nanosensors: Global Markets and Technologies" report has been added to ResearchAndMarkets.com's offering. The global market for biosensors and nanosensors was valued at $28.7 billion in 2022 and is expected to reach $43.5 billion by 2028 growing at a CAGR of 7.3% from 2023 to 2028. North America accounts for the largest market share of the market, followed by Europe and Asia-Pacific. via Business Wire Health: Medical Devices News

🌟 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝗼𝗿𝗮𝗹 𝗱𝗿𝘂𝗴 𝗧𝗵𝗲𝗿𝗮𝗽𝘆: 𝗧𝗵𝗲 "𝗲-𝗣𝗶𝗹𝗹𝗲" 💊 COMPAMED – Düsseldorf / Deutschland 𝗳𝗿𝗼𝗺 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟭𝟭–𝟭𝟰, 𝟮𝟬𝟮𝟰! 🚀 𝗪𝗵𝗮𝘁 𝗶𝘀 𝗮𝗯𝗼𝘂𝘁 𝘁𝗵𝗲 "𝗲-𝗣𝗶𝗹𝗹𝗲"💊? As temperatures drop, many turn to cough and headache tablets. But how well are these medications absorbed in the gastrointestinal tract? 🤔 In the "𝗲-𝗣𝗶𝗹𝗹𝗲" research project, scientists from the Fraunhofer Institutes Fraunhofer ITMP, Fraunhofer IZM and Fraunhofer EMFT are optimizing medication absorption! Previously, uncomfortable intubation studies were the only way to investigate medication absorption. The 𝗲𝗹𝗲𝗰𝘁𝗿𝗼𝗻𝗶𝗰𝗮𝗹𝗹𝘆 𝗰𝗼𝗻𝘁𝗿𝗼𝗹𝗹𝗲𝗱 𝗰𝗮𝗽𝘀𝘂𝗹𝗲𝘀 were often so large and difficult to swallow that they posed an additional challenge. 😣 📏 𝗧𝗵𝗲 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻: 𝗠𝗶𝗻𝗶𝗮𝘁𝘂𝗿𝗶𝘇𝗲𝗱 𝗖𝗮𝗽𝘀𝘂𝗹𝗲𝘀! Our #FraunhoferEMFT researchers have reduced the capsule to the size of a multivitamin tablet. This innovative electronic capsule releases the test medication exactly where it's needed in the gastrointestinal tract - controlled by an electronic signal. This not only makes intake significantly easier but also ensures precise dosing. 🚀💊 ➡️ Learn more: https://lnkd.in/dQVA9EnS Our researches Christian Wald, Anne Zimmermann, Daniel Anheuer and Lorenz Grünerbel look forward to engaging conversations at our 𝗙𝗿𝗮𝘂𝗻𝗵𝗼𝗳𝗲𝗿 𝗘𝗠𝗙𝗧 𝗦𝘁𝗮𝗻𝗱 𝟭𝟰 𝗶𝗻 📍 𝗛𝗮𝗹𝗹 𝟴𝗮/𝗥𝟭𝟮 at COMPAMED – Düsseldorf / Deutschland, where you can discover many more topics related to medical research! Fraunhofer-Gesellschaft FMD - Forschungsfabrik Mikroelektronik Deutschland #FutureOfMedicine #MedicationResearch #Comapmed2024 #MedicalInnovation #DigitalHealth #MinituarizedCapsules

Contrast Media Injectors Market Size to Hit USD 2.3 Billion by 2029 📑 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐏𝐃𝐅: https://lnkd.in/dJHZT784 The size of global contrast media injectors market in terms of revenue was estimated to be worth $1.6 billion in 2024 and is poised to reach $2.3 billion by 2029, growing at a CAGR of 8.0% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Bayer Bracco Imaging Korea Guerbet ULRICH GMBH & CO. KG MEDTRON AG Nemoto Portugal, Química Fina, Unipessoal, Lda. Shenzhen Anke High-Tech Co.,Ltd. APOLLO RT Corporation Limited Shenzhen Seacrown Electromechanical Co., Ltd. Shenzhen Antmed Co., Ltd. Union Medical Shenzhen Co., Ltd. Spectrum Medical Technologies Shenzhen Boon Medical Supply Co.LTD SCW Medicath VYGON Nanjing Foinoe Co.,LTD Lemer Pax Comecer Tema Sinergie Qingdao Hiprove Medical Technologies Co.,Ltd. Shanghai Kindly Enterprise Development Group Co., Ltd

Exciting times ahead! It is very important to fill the gap which was recently created in the viscoelastometry market. I am absolutely convinced that the market needs a flexible modern platform for viscoelastometry also in the future. ROTEM (r) delta and TEG (r) 5000 were introduced 20+ years ago, and are clearly ageing. ROTEM (r) sigma, TEG (r) 6s and the Quantra (r) system with their 4 channel cartridges are easy to use, but rather inflexible and relatively expensive to operate. Thus in my opinion these cartridge-based viscoelastometry devices are not the optimal solution for all customers, or all countries. Let´s look forward to MultiClot! #apiro #multiclot

Likely to be effective next year, GE HealthCare will assume full control of Nihon Medi-Physics Co., Ltd. (NMP), a Japanese diagnostic radiopharmaceuticals and molecular imaging agents producer. Earlier GE HealthCare was a 50:50 joint venture partner of Sumitomo Chemical, operating a company in Tokyo, Japan. The full control is planned to take place by the end of March 2025 through the purchase of the remaining 50% of the shares. #GEHealthCare #NMP #Japan #HealthCare #LifeSciences

Following a successful pilot program with select hospitals last year, Elutia announces a full U.S. commercial launch of EluPro, an FDA-cleared antibiotic-eluting biomatrix for implantable electronic devices and neurostimulators. Read full announcement here: https://lnkd.in/g3GPSUMU #implantabledevices #healthech #biotech #elutia #highcape